AAIC 2022 and Treatment View overview page

Phase II trial of XPro1595 for the treatment of Alzheimer’s disease

Viral-mediated gene therapy for neurodegenerative disease

Improving the precision and safety of CRISPR/Cas genome editing

EXERT: why was strength/balance training as effective as cardio in preventing cognitive decline?

How does exercise affect cognition?

The neurogenesis hypothesis: NA-831 for the treatment of Alzheimer’s disease

Progress in the Davos Alzheimer’s Collaborative’s Global Cohort Development program

Investigating CT1812: an S2R modulator in development for Alzheimer’s disease

Investigational S2R modulator CT1812 affects key proteins in Alzheimer’s disease

The Davos Alzheimer’s Collaborative

Using digital technology to build a truly global cohort in Alzheimer’s disease

Phase II study of S2R modulation in patients with dementia with Lewy bodies

TOGETHER study: updates on bepranemab as a potential treatment for AD

Next steps in VCID research: molecular targets and fluid biomarkers

I-CONECT: effect of online conversations on psychosocial wellbeing in older adults

Buntanetap mechanism of action